Fralex Therapeutics Inc. is dedicated to improving quality of life through the use of neuromodulation therapy. Our technology – known as the Complex Neural Pulse (CNP) – is being developed as a non-drug alternative for the treatment of chronic pain.

Further applications are planned in the treatment of depression and anxiety.


Pain Associated with Fibromyalgia – Pivotal Clinical Trial

Fralex is sponsoring a pivotal clinical trial at sites across the U.S. and Canada investigating the safety and efficacy of CNP in the treatment of pain associated with fibromyalgia.

For more information, click the image above to access the RELIEF trial website, or ClinicalTrials.gov, or call Fralex at 1-877-213-8118.

What is Fibromyalgia Syndrome (FMS)?
It is a clinical syndrome characterized by chronic, widespread, musculoskeletal pain with no discernable cause. Other symptoms may include: sleep disturbance, fatigue, stiffness while walking, headaches, memory and concentration
difficulties, numbness and tingling, itching, fluid retention, and abdominal or pelvic pain.
8 – 12 Million people in the United States are suffering from this syndrome. The cause of FMS is not well understood and the diagnosis of FMS is difficult due to other symptoms resembling other chronic pain conditions.
It is further complicated because of the existence of various psychiatric disorders, including major depressive disorder, generalized anxiety disorder and irritable bowel syndrome, to name a few.

Press Releases

May 8, 2008 Fralex announces Fiscal 2008 First Quarter Results

March 31, 2008 Fralex announces 2007 Fourth Quarter and Year-End Results

March 10, 2008 Fralex reaches 100th patient milestone in fibromyalgia study

November 12, 2007 Fralex announces fiscal 2007 third quarter results

November 9, 2007 Fralex welcomes David Chazanovitz to Board of Directors

September 20, 2007 Fralex announces CE marking of PRIMA device

Note: The above documents are in PDF format.


Fast Facts
  • Head Office: Toronto, Canada
  • Founded: 1998
  • Technology: Complex Neural Pulse (CNP)
  • President and CEO:
    Avi Grewal